Authors: BONISTALLI L BARDELLI F COSTANTINI M TRALLORI G DALBASIO G MESSORI A

Citation: L. Bonistalli et al., ADJUVANT CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE-III COLON-CANCER - LIFETIME COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS, The Cancer journal, 11(1), 1998, pp. 39-47

Authors: MESSORI A COSTANTINI M BONISTALLI L ALTERINI R

Citation: A. Messori et al., 2ND BONE-MARROW TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(2), 1998, pp. 804-806

Authors: MESSORI A BONISTALLI L COSTANTINI M ALTERINI R

Citation: A. Messori et al., COST-EFFECTIVENESS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(3), 1997, pp. 275-281

Authors: MESSORI A BONISTALLI L COSTANTINI M TRALLORI G TENDI E

Citation: A. Messori et al., COST-EFFECTIVENESS OF ADJUVANT INTRAPORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER, Journal of clinical gastroenterology, 23(4), 1996, pp. 269-274